238 related articles for article (PubMed ID: 31847854)
1. When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest.
Ehrlich O; Wingate L; Heller C; de Melo-Martin I
BMC Med Ethics; 2019 Dec; 20(1):96. PubMed ID: 31847854
[TBL] [Abstract][Full Text] [Related]
2. Patient Advocacy Organizations, Industry Funding, and Conflicts of Interest.
Rose SL; Highland J; Karafa MT; Joffe S
JAMA Intern Med; 2017 Mar; 177(3):344-350. PubMed ID: 28114624
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Potential Conflicts of Interest among Otolaryngologic Patient Advocacy Organizations in 2016.
Kondamuri NS; Rathi VK; Naunheim MR; Sethi RV; Miller AL; Varvares MA
Otolaryngol Head Neck Surg; 2019 Dec; 161(6):967-969. PubMed ID: 31479391
[TBL] [Abstract][Full Text] [Related]
4. A Content Analysis of Patient Advocacy Organization Policies Addressing Institutional Conflicts of Interest.
Brems JH; McCoy MS
AJOB Empir Bioeth; 2019; 10(4):215-221. PubMed ID: 31593523
[No Abstract] [Full Text] [Related]
5. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
Shnier A; Lexchin J; Romero M; Brown K
BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247
[TBL] [Abstract][Full Text] [Related]
6. A new method for scoring financial conflicts of interest.
Maharaj SV
Int J Occup Environ Health; 2015; 21(1):49-52. PubMed ID: 25633929
[TBL] [Abstract][Full Text] [Related]
7. Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness.
Rose SL
J Law Med Ethics; 2013; 41(3):680-7. PubMed ID: 24088159
[TBL] [Abstract][Full Text] [Related]
8. Conflicts of interest in research involving human beings.
Greco D; Diniz NM
J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.
Li DG; Singer S; Mostaghimi A
JAMA Dermatol; 2019 Apr; 155(4):460-464. PubMed ID: 30698625
[TBL] [Abstract][Full Text] [Related]
10. Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors.
Mitchell AP; Basch EM; Dusetzina SB
JAMA Oncol; 2016 Dec; 2(12):1628-1631. PubMed ID: 27561170
[TBL] [Abstract][Full Text] [Related]
11. Authors of clinical trials seldom reported details when declaring their individual and institutional financial conflicts of interest: a cross-sectional survey.
Hakoum MB; Noureldine H; Habib JR; Abou-Jaoude EA; Raslan R; Jouni N; Hasbani DJ; Lopes LC; Guyatt G; Akl EA
J Clin Epidemiol; 2020 Nov; 127():49-58. PubMed ID: 32512186
[TBL] [Abstract][Full Text] [Related]
12. Financial conflicts of interest and the NIH.
Steinbrook R
N Engl J Med; 2004 Jan; 350(4):327-30. PubMed ID: 14736923
[No Abstract] [Full Text] [Related]
13. Scope and impact of financial conflicts of interest in biomedical research: a systematic review.
Bekelman JE; Li Y; Gross CP
JAMA; 2003 Jan 22-29; 289(4):454-65. PubMed ID: 12533125
[TBL] [Abstract][Full Text] [Related]
14. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
Tereskerz PM
Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
[No Abstract] [Full Text] [Related]
15. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study.
Elder K; Turner KA; Cosgrove L; Lexchin J; Shnier A; Moore A; Straus S; Thombs BD
CMAJ; 2020 Jun; 192(23):E617-E625. PubMed ID: 32538799
[TBL] [Abstract][Full Text] [Related]
16. Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research.
Tereskerz PM; Moreno J
Account Res; 2005; 12(2):139-55. PubMed ID: 16220626
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical Industry Support of US Patient Advocacy Organizations: An International Context.
Kang SY; Bai G; Karas L; Anderson GF
Am J Public Health; 2019 Apr; 109(4):559-561. PubMed ID: 30789768
[TBL] [Abstract][Full Text] [Related]
18. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
Puttagunta PS; Caulfield TA; Griener G
Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309
[TBL] [Abstract][Full Text] [Related]
19. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
[TBL] [Abstract][Full Text] [Related]
20. Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research.
AAMC Task Force on Financial Conflicts of Interest in Clinical Research
Acad Med; 2003 Feb; 78(2):225-36. PubMed ID: 12584106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
